Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Non-Current Deffered Revenue (2020 - 2021)

BioAtla's Non-Current Deffered Revenue history spans 2 years, with the latest figure at $1.7 million for Q3 2021.

  • For Q3 2021, Non-Current Deffered Revenue changed N/A year-over-year to $1.7 million; the TTM value through Sep 2021 reached $1.7 million, changed N/A, while the annual FY2020 figure was $2.0 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue reached $1.7 million in Q3 2021 per BCAB's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.0 million in Q4 2020 to a low of $1.7 million in Q3 2021.